Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,611.20
(
0.27%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.71
(
-2.36%
)
Bitcoin
70,928.00
(
-0.62%
)
News Focus
News Focus

Replies to post #4687 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #4687 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

GrthzGd

08/04/11 12:10 PM

#4691 RE: DewDiligence #4687

Agreed, as CW said, there's too much competition in the space to justify trials, including from Enoxaparin itself.